Correction: PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix.

Journal

Oncotarget
ISSN: 1949-2553
Titre abrégé: Oncotarget
Pays: United States
ID NLM: 101532965

Informations de publication

Date de publication:
30 Jul 2019
Historique:
entrez: 16 8 2019
pubmed: 16 8 2019
medline: 16 8 2019
Statut: epublish

Résumé

[This corrects the article DOI: 10.18632/oncotarget.27008.].

Identifiants

DOI: 10.18632/oncotarget.27101 PMID: 31413820 PMC: PMC6677665
pubmed: 31413820
doi: 10.18632/oncotarget.27101
pii: 27101
pmc: PMC6677665
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

4802

Commentaires et corrections

Type : ErratumFor

Auteurs

Minakshi Mann (M)

Department of Medical Oncology, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.

Sachin Kumar (S)

Department of Medical Oncology, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.

Shyam S Chauhan (SS)

Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.

Neerja Bhatla (N)

Department of Obstetrics and Gynecology, All India Institute of Medical Sciences, New Delhi, India.

Sunesh Kumar (S)

Department of Obstetrics and Gynecology, All India Institute of Medical Sciences, New Delhi, India.

Sameer Bakhshi (S)

Department of Medical Oncology, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.

Ritu Gupta (R)

Laboratory Oncology Unit, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.

Ashok Sharma (A)

Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.

Lalit Kumar (L)

Department of Medical Oncology, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.

Classifications MeSH